HTR4 and gastroesophageal reflux disease: In addition, a stimulation of esophageal body contraction and an elevation of lower esophagus sphincter (LES) resting pressure was also shown for mosapride, another selective 5-HT4-agonist [24], and is, therefore, used for GERD patients (in combination with PPI) in some Asian countries [25].